Mission Therapeutics: Venture Capital Funding History

Mission Therapeutics raises £10m in follow-on funding from investors to advance mitophagy-based Parkinson's therapy

Mission Therapeutics develops drugs that enhance mitophagy, advancing treatments for Parkinson’s disease by targeting mitochondrial health in neurons.